Ben Duffy/Sherdog.com illustration
T.J. Dillashaw
Fans have grown accustomed to fighters who torpedo their careers by trying to gain a competitive edge illegally, so when Dillashaw was flagged and subsequently suspended for his use of the performance-enhancing drug recombinant human erythropoietin. The former Ultimate Fighting Championship bantamweight titleholder will spend the next two years on the sidelines, ineligible to return to competition until Jan 19, 2021.
Roughly two months later, Dillashaw vacated the bantamweight championship when it was revealed he flunked pre- and post-fight drug screens.
“We all know the pressures to win at all levels of all sport are real and intense,” United States Anti-Doping Agency CEO Travis T. Tygart said. “It is exactly why strong anti-doping efforts are necessary to protect clean athletes’ rights, health and safety and to ensure that those who do succumb to these pressures and decide to break the rules will be held accountable in a real and meaningful way, as in this case.”
Continue Reading » Not So Cuddly